Zhengye Biotechnology Holding (ZYBT) Long-Term Deferred Tax (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Long-Term Deferred Tax for 3 consecutive years, with $14663.2 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Long-Term Deferred Tax fell 99.04% year-over-year to $14663.2 in Q4 2025; TTM through Dec 2025 was $14663.2, a 99.04% decrease from a year earlier, with the FY2025 full-year figure at $15000.0, down 99.0% from the prior year.
• Long-Term Deferred Tax was $14663.2 for Q4 2025 at Zhengye Biotechnology Holding, down from $2.3 million in the prior quarter.
• Over five years, Long-Term Deferred Tax peaked at $2.3 million in Q2 2025 and troughed at $14663.2 in Q4 2025.
• A 3-year average of $1.4 million and a median of $1.6 million in 2023 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax fell 7.53% in 2024 and slumped 99.04% in 2025, its largest moves.
• Over 3 years, Long-Term Deferred Tax stood at $1.7 million in 2023, then decreased by 7.53% to $1.5 million in 2024, then sank by 99.04% to $14663.2 in 2025.
• The last three Long-Term Deferred Tax figures came in at $14663.2 (Q4 2025), $2.3 million (Q2 2025), and $1.5 million (Q4 2024), per Business Quant data.